213 related articles for article (PubMed ID: 36498660)
1. Safety and Efficacy of the Preserflo
Majoulet A; Scemla B; Hamard P; Brasnu E; Hage A; Baudouin C; Labbé A
J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498660
[No Abstract] [Full Text] [Related]
2. Efficacy and Safety of PreserFlo
Quaranta L; Micheletti E; Carassa R; Bruttini C; Fausto R; Katsanos A; Riva I
Adv Ther; 2021 Aug; 38(8):4403-4412. PubMed ID: 34251652
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes and Cost Analysis of PreserFlo versus Trabeculectomy for Glaucoma Management in the United Kingdom.
Van Lancker L; Saravanan A; Abu-Bakra M; Reid K; Quijano C; Goyal S; Rodrigues I; Lascaratos G; Trikha S; Barwood C; Combe E; Kulkarni A; Lim KS; Low S
Ophthalmol Glaucoma; 2023; 6(4):342-357. PubMed ID: 36427750
[TBL] [Abstract][Full Text] [Related]
4. One Year Results of the Preserflo MicroShunt Implantation for Refractory Glaucoma.
Seuthe AM; Erokhina M; Szurman P; Haus A
J Glaucoma; 2023 May; 32(5):414-419. PubMed ID: 36795529
[TBL] [Abstract][Full Text] [Related]
5. Device-modified trabeculectomy for glaucoma.
Park J; Rittiphairoj T; Wang X; E JY; Bicket AK
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010472. PubMed ID: 36912740
[TBL] [Abstract][Full Text] [Related]
6. PreserFlo™ MicroShunt Versus Trabeculectomy in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Prospective Study.
Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Kohlhaas M
Cureus; 2022 Aug; 14(8):e28288. PubMed ID: 36158358
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study.
Fea AM; Laffi GL; Martini E; Economou MA; Caselgrandi P; Sacchi M; Au L
Ophthalmol Glaucoma; 2022; 5(2):210-218. PubMed ID: 34478904
[TBL] [Abstract][Full Text] [Related]
8. One-year outcomes of stand-alone ab externo SIBS microshunt implantation in refractory glaucoma.
Durr GM; Schlenker MB; Samet S; Ahmed IIK
Br J Ophthalmol; 2022 Jan; 106(1):71-79. PubMed ID: 33097520
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma.
Strzalkowska A; Strzalkowski P; Hoffmann EM; Pfeiffer N; Schuster AK
J Glaucoma; 2023 Aug; 32(8):681-685. PubMed ID: 37327469
[TBL] [Abstract][Full Text] [Related]
10. One-Year Outcomes of Preserflo
Nobl M; Grün C; Kassumeh S; Priglinger S; Mackert MJ
J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109334
[TBL] [Abstract][Full Text] [Related]
11. XEN
Scheres LMJ; Kujovic-Aleksov S; Ramdas WD; de Crom RMPC; Roelofs LCG; Berendschot TTJM; Webers CAB; Beckers HJM
Acta Ophthalmol; 2021 May; 99(3):e433-e440. PubMed ID: 32909682
[TBL] [Abstract][Full Text] [Related]
12. Ab Externo SIBS Microshunt with Mitomycin C for Open-Angle Glaucoma: Three-Year Results as a Primary Surgical Intervention.
Armstrong JJ; De Francesco T; Ma J; Schlenker MB; Ahmed IIK
Ophthalmol Glaucoma; 2023; 6(5):480-492. PubMed ID: 37044278
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation.
Vastardis I; Fili S; Perdikakis G; Kontopoulou K; Balidis M; Gatzioufas Z; Kohlhaas M
Eye Vis (Lond); 2021 Sep; 8(1):33. PubMed ID: 34479641
[TBL] [Abstract][Full Text] [Related]
14. One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis.
Tanner A; Haddad F; Fajardo-Sanchez J; Nguyen E; Thong KX; Ah-Moye S; Perl N; Abu-Bakra M; Kulkarni A; Trikha S; Lascaratos G; Parnell M; Kailani O; King AJ; Agrawal P; Stead R; Giannouladis K; Rodrigues I; Goyal S; Hysi PG; Lim S; Yu-Wai-Man C
Br J Ophthalmol; 2023 Aug; 107(8):1104-1111. PubMed ID: 35365491
[TBL] [Abstract][Full Text] [Related]
15. Preserflo TM MicroShunt implantation combined with Ologen TM in primary and secondary glaucoma patients in a clinical setting.
Rojo-Arnao M; Martinez-de-la-Casa JM; Albis-Donado O; Yañez-Castro G; Maroto-Cejudo R; Téllez J; Menoyo-Calatayud R
Indian J Ophthalmol; 2024 Mar; 72(3):417-426. PubMed ID: 38153975
[TBL] [Abstract][Full Text] [Related]
16. Comparing the safety and efficacy of Preserflo Microshunt implantation and trabeculectomy for glaucoma: A systematic review and meta-analysis.
Khan A; Khan AU
Acta Ophthalmol; 2024 Jun; 102(4):e443-e451. PubMed ID: 38376121
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the PRESERFLO MicroShunt and a Meta-Analysis of the Literature.
Pawiroredjo SSM; Bramer WM; Pawiroredjo ND; Pals J; Poelman HJ; de Vries VA; Wolfs RCW; Ramdas WD
J Clin Med; 2022 Dec; 11(23):. PubMed ID: 36498729
[TBL] [Abstract][Full Text] [Related]
18. Blood Reflux Through a PreserFlo MicroShunt Device After Needling.
Cassottana P; Di Mola I; Ferro Desideri L; Vagge A; Cutolo CA; Traverso CE; Iester M
J Glaucoma; 2022 Dec; 31(12):979-981. PubMed ID: 35939834
[TBL] [Abstract][Full Text] [Related]
19. Inter-eye relationship of intraocular pressure change after unilateral trabeculectomy, filtering canaloplasty, or PreserFlo™ microshunt implantation.
Aghayeva FA; Chronopoulos P; Schuster AK; Pfeiffer N; Hoffmann EM
Graefes Arch Clin Exp Ophthalmol; 2021 Oct; 259(10):3045-3053. PubMed ID: 33963917
[TBL] [Abstract][Full Text] [Related]
20. PRESERFLO ™ MicroShunt versus trabeculectomy: 1-year results on efficacy and safety.
Jamke M; Herber R; Haase MA; Jasper CS; Pillunat LE; Pillunat KR
Graefes Arch Clin Exp Ophthalmol; 2023 Oct; 261(10):2901-2915. PubMed ID: 37133501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
